Cingulate

Pharmaceutical companies in Kansas City, United States
Suggest an edit · Your business? Claim now

Add more information

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Releaseâ„¢ (PTR) drug delivery platform technology to build and …

Social profiles

Frequently asked questions

Q:
When did Cingulate become a public company? What was the IPO price?
A:
Cingulate became a public company on December 07, 2021 at an initial public offering price of $6 per share.
Data from: BusinessWebsite
Oops! Something went wrong, Please try again after a few minutes